Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions (VIgIE)
Sponsor: Agence de La Biomédecine
This observational or N/A phase trial investigates Renal Insufficiency and is currently completed. Agence de La Biomédecine leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Agence de La Biomédecine
- Central Hospital, Nancy, France
- Centre Hospitalier Universitaire de Besancon
- Observatoire Régional de la Santé d'Alsace
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .